Henri Termeer joins Prosensa as Strategic Advisor
We are so pleased to see the high caliber of professionals joining in the fight to cure Duchenne. Henri Termeer served as Chairman, President and CEO of Genzyme Corporation for nearly three decades. He created a system where patients with rare diseases were able to have access to very expensive drugs. He joins an incredible management team at Prosensa.